SCHEMBL5376751

SCHEMBL5376751

Cc1cccc(-c2nc3ccc(C(C)(C)c4ccccc4)cc3c(=O)o2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
PBRM1 Q86U86 1/20 0.51
CNR1 P21554 2/20 0.49
CNR2 P34972 2/20 0.49
KMT2A Q03164 6/20 0.48
ALDH1A1 P00352 4/20 0.48
F2 P00734 1/20 0.48
HPGD P15428 1/20 0.48
C1R P00736 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
MEN1 O00255 5/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAPT P10636 3/20 0.47
HSD17B10 Q99714 1/20 0.47
ELANE P08246 2/20 0.47
HPN P05981 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5382664 0.90 ELANE (0.57) KDM4EKMT2AALDH1A1F2HPGD
SCHEMBL14462683 0.88 NPC1 (0.55) KDM4EKMT2AALDH1A1F2HPGD
SCHEMBL5385483 0.87 F7 (0.49) KDM4EKMT2AALDH1A1F2HPGD
SCHEMBL5382380 0.85 ALDH1A1 (0.69) KDM4EKMT2AALDH1A1F2HPGD
SCHEMBL914389 0.84 ALDH1A1 (0.61) KDM4EPBRM1KMT2AALDH1A1F2
SCHEMBL5380224 0.82 NPC1 (0.49) KDM4EKMT2AALDH1A1HPGDC1R
SCHEMBL5391365 0.82 ALDH1A1 (0.51) KDM4EKMT2AALDH1A1F2HPGD
SCHEMBL14462682 0.81 F7 (0.45) KDM4EKMT2AALDH1A1F2HPGD
SCHEMBL914659 0.81 ELANE (0.71) KDM4EPBRM1KMT2AALDH1A1F2
SCHEMBL5378586 0.81 ALDH1A1 (0.66) KDM4EKMT2AALDH1A1F2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7244776-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-07-17 US disclosed
US-20070100031-A1 Ultraviolet light absorbers RAVICHANDRAN RAMANATHAN 2007-05-03 US disclosed
US-7173128-B2 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION (US) 2007-02-06 US disclosed
US-20040192684-A1 Ultraviolet light absorbers CIBA SPECIALTY CHEMICALS CORPORATION 2004-09-30 US disclosed
EP-1430038-A1 ULTRAVIOLET LIGHT ABSORBERS Ciba SC Holding AG (CH) 2004-06-23 EP disclosed
WO-2003016292-A1 ULTRAVIOLET LIGHT ABSORBERS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040192684-A1 Ultraviolet light absorbers UNG, MSH6, MAL2 KDM4E 442/4885PBRM1 987/4885CNR1 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.